Cent Eur J Public Health 2012, 20(4):239-243 | DOI: 10.21101/cejph.a3755

Nineteen Years Study of Beta-Thalassaemia in Slovakia

Viera Fábryová1, Pavol Babušík2, Zuzana Laluhová-Striežencová3, Monika Drakulová4, Martina Oslancová3, Martina Macichová5, Adriana Sakalová6
1 Department of Haematology, Military Hospital, Bratislava, Slovakia
2 Laboratory of Molecular Genetics, ProGen Company, Nitra, Slovakia
3 Department of Haematology, Pediatric Faculty Hospital and Clinic, Bratislava, Slovakia
4 Laboratory of Haematology, Synlab Company, University Hospital in Kramáre, Bratislava, Slovakia
5 Department of Haematology, L. Pasteur Faculty Hospital, Košice, Slovakia
6 Department of Haematology and Transfusiology, Slovak Postgradual University, Bratislava, Slovakia

Background: Beta-thalassaemia is a congenital disorder caused by point mutations in a haemoglobin beta-globin chain. The heterozygous form produces microcytosis and normal iron levels, however, haemoglobin electrophoresis shows elevated amounts of haemoglobin A2 and eventually foetal haemoglobin F as well.

Methods: Between 2005-2011, in three centres in Slovakia, carriers of beta-thalassaemic genes or other haemoglobinopathies were searched for. Diagnosis was performed by haematologists whereby the family history was evaluated, together with the overall clinical condition, blood count and blood smear, iron parameters, haemolysis and haemoglobin electrophoresis testing. A proportion of patients was examined by molecular genetic methods.

Results: A clinical suspicion of the heterozygous form of beta-thalassaemia was documented in 402 patients (21.9%) out of a total of 1,834 examinations. From these patients, 87 underwent molecular genetic testing and mutations of beta globin genes were identified in 70 of them, where the most frequent mutations were IVS 2.1 (28.5%), IVS 1.110 (25.6%) and IVS 1.1 (11.3%). Evidence of haemoglobin S (sickle cell anaemia) was also notable in one case (patient of African origin). Unusually high levels of haemoglobin F (6-21%) were found in 23 adult subjects.

Conclusion: The study showed that there is a higher number of heterozygotes for beta-thalassaemia and rarely haemoglobinopathies. It is necessary to continue in search of pathological gene carriers in Slovakia.

Keywords: beta-thalassaemia, beta-globin chain, gene mutation, epidemiological study

Received: December 16, 2011; Revised: July 2, 2012; Accepted: July 2, 2012; Published: December 1, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Fábryová V, Babušík P, Laluhová-Striežencová Z, Drakulová M, Oslancová M, Macichová M, Sakalová A. Nineteen Years Study of Beta-Thalassaemia in Slovakia. Cent Eur J Public Health. 2012;20(4):239-243. doi: 10.21101/cejph.a3755. PubMed PMID: 23441384.
Download citation

References

  1. Fábryová V, Sakalová A. Latest news in the diagnostics, treatment and prevention of beta-thalassemia. Lek Obz. 2006 Oct;55(10):430-2. (In Slovak.)
  2. Fábryová V. Beta-talasémie. Bratislava: Herba; 2007. (In Slovak.)
  3. Harano T. Hemoglobinopathy. Kobe (Japan): Sysmex Corp; 2004.
  4. Madan N, Sharma S, Sood SK, Colah R, Bhatia LH. Frequency of β-thalassemia trait and other hemoglobinopathies in northern and western India. Indian J Hum Genet. 2010 Jan;16(1):16-25. Go to original source... Go to PubMed...
  5. Al-Arrayed SS. Beta thalassemia frequency in Bahrain: a ten year study. Bahrain Med Bull. 2010;32(2):1-5.
  6. Ginsberg G, Tulchinsky T, Filon D, Goldfarb A, Abramov L, Rachmilevitz EA. Cost-benefit analysis of a national thalassaemia prevention programme in Israel. J Med Screen. 1998;5(3):120-6. Go to original source... Go to PubMed...
  7. Cao A, Rosatelli MC, Galanello R. Control of beta-thalassaemia by carrier screening, genetic counselling and prenatal diagnosis: the Sardinian experience. Ciba Found Symp. 1996;197:137-51. Go to original source... Go to PubMed...
  8. Galanello R, Eleftheriou A, Traeger-Synodinos J, Old J, Petrou M, Angastiniotis M, editors. Prevention of thalassaemias and other haemoglobin disorders. Nicosia: Thalassaemia International Federation; 2003.
  9. Cario H, Stahnke K, Sander S, Kohne E. Epidemiological situation and treatment of patients with thalassemia major in Germany: results of the German multicenter beta-thalassemia study. Ann Hematol. 2000 Jan;79(1):7-12. Go to original source... Go to PubMed...
  10. Dankwa E, Killer D, Fischer S, Marti HR. Incidence of thalassemia in Switzerland. Schweiz Med Wochenschr. 1975 Jan 25;105(4):102-5. (In German.) Go to PubMed...
  11. Frecus CE. Beta-thalassemia trait - epidemiological and clinical aspects in children in Constanta County [Ph.D. thesis]. University of Medicine and Pharmacy Craiova Faculty of General Medicine; 2010.
  12. Modell B, Khan M, Darlison M. Survival in beta-thalassaemia major in the UK: data from the UK Thalassaemia Register. Lancet. 2000 Jun 10;355(9220):2051-2. Go to original source... Go to PubMed...
  13. Wonke B, Modell M, Marlow T, Khan M, Modell B. Microcytosis, iron deficiency and thalassaemia in a multi-ethnic community: a pilot study. Scand J Clin Lab Invest. 2007;67(1):87-96. Go to original source... Go to PubMed...
  14. Modell B, Darlison M, Birgens H, Cario H, Faustino P, Giordano PC, et al. Epidemiology of haemoglobin disorders in Europe: an overview. Scand J Clin Lab Invest. 2007;67(1):39-70. Go to original source... Go to PubMed...
  15. Mañú Pereira M, Vives Corrons JL. Neonatal haemoglobinopathy screening in Spain. J Clin Pathol. 2009 Jan;62(1):22-5. Go to original source... Go to PubMed...
  16. Modell B, Darlison M. Global epidemiology of haemoglobin disorders and derived service indicators. Bull World Health Organ. 2008 Jun;86(6):4807. Go to original source...
  17. Bain BJ. Haemoglobinopathy diagnosis. Oxford: Blackwell Publishing; 2006. Go to original source...
  18. StreetlyA, Latinovic R, Hall K, Henthorn J. Implementation of universal newborn bloodspot screening for sickle cell disease and other clinically significant haemoglobinopathies in England: screening results for 2005-7. J Clin Pathol. 2009 Jan;62(1):26-30. Go to original source... Go to PubMed...
  19. Indrák K, Divoký V, Brabec V, Chrobák L, Mociková K, Sakalová A, et al. Dominant beta-thalassaemie alleles in the Czech and Slovak population (beta-thalassaemie mutations in the codons 112 (TA) and 121 (GT) amd unstable hemoglobin varriants Hradec Králové or alpha, 2, beta, 2, 115 (G17 Ala-Asp). Vnitr Lek. 1994;40(4):223-30. Go to PubMed...
  20. Lenna-Russo D. Research profile on biomed experts, 2007 [Internet]. Elsevier; 2011 [cited 2012 Jun 11]. Available from: http://www.biomedexperts.com/.
  21. Weatherall DJ. The inherited diseases of hemoglobin are an emerging global health burden. Blood. 2010 Jun 3;115(22):4331-6. Go to original source... Go to PubMed...
  22. Weatherall DJ. Thalassaemia: the biography. Oxford: Oxford University Press; 2010.